Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells

Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells

The study is to investigate the efficacy and safety of allogenous transplantation of adipose-derived mesenchyma stem cells in patients with cerebellar ataxia.

Inclusion Criteria:

• Patients diagnosed of spinocerebellar ataxia 3 (SCA3) or multiple system atrophy-cerebellar (MSA-C).
• Subject's SARA score at 10~20 points.
• Ages between 20~70 years.
• Signed informed consent from the patient and/or guardian.

Exclusion Criteria:

• Subjects enrolled in any other cell therapy studies within the past 30 days.
• Pregnancy test positive.
• Subjects deemed to be not suitable for the study by the investigator.